Objective. Most clinicians use the 2006 Sydney classification criteria to evaluate patients
suspected of having antiphospholipid syndrome (APS). Although sensitive and specific for APS, …

I was pleased to read the letter by Zhang, et al1 regarding our November 2017 published
work,“Closing the Serological Gap in Antiphospholipid Syndrome: The Value of ‘Non-criteria’…

… Zohoury did not personally participate in this study or have any relationship with the authors,
another Inova employee was a participant in the source paper by Zhang, et al, referenced …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by frequent clotting
in arteries and veins and/or miscarriages. Autoantibodies to phospholipids and to beta 2 …

… , and we said yes to all of them,” says Navid Zohoury, co–lead organizer of the event and
a chemist … “We're trying to demystify science,” says Zohoury, who hopes the trademarked “Two …

The authors and the publisher of this volume have taken care that the information and
recommendations contained herein are accurate and compatible with the standards generally …

Background Antibodies binding to domain I of β 2 -glycoprotein I (aDI) and activated protein
C (APC) resistance are associated with an increased risk of thrombosis in cross-sectional …

Background: Antibodies binding to domain I of β 2 -glycoprotein I (aDI) and activated protein
C (APC) resistance are associated with an increased risk of thrombosis in cross-sectional …

Beta-2 glycoprotein I (β2GPI) is the main antigenic target for anti-phospholipid antibodies (aPL),
the serological markers of anti-phospholipid syndrome (APS). Conformational changes …

Aims and objectives Antiphospholipid syndrome (APS) is characterized by pregnancy
complications, recurrent arterial and venous thrombosis affecting one or more organs and tissues …